Elsevier

Atherosclerosis

Volume 106, Issue 1, March 1994, Pages 9-19
Atherosclerosis

Research paper
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

https://doi.org/10.1016/0021-9150(94)90078-7Get rights and content

Abstract

The relation of serum total homocysteine and lipoprotein(a) (Lp(a)) with the incidence of atherosclerotic disease was investigated among 7424 men and women aged 40–64 years free of atherosclerotic disease at baseline in 1977. During the 9-year follow-up, 134 male and 131 female cases with either myocardial infarction or stroke were identified. For each case a control subject was selected belonging to the same sex and 5-year age group. Serum samples collected in 1977 were stored at −20°C and analyzed in 1991. The mean serum homocysteine concentration of male cases and controls was 9,99 μmol/1 and 9.82 μmol/l at baseline and that of female cases and controls 9.58 μmol/l and 9.241μmol/1, respectively. The median serum Lp(a) concentration of male cases and controls was 73 mg/l and 108 mg/l and that of female cases and controls 113 mg/l and 91 mg/l, respectively. The differences between cases and controls were not statistically significant. There was also no significant association between either homocysteine or Lp(a) and atherosclerotic disease, myocardial infarction or stroke in logistic regression analyses. The odds ratios varied from l.00 to l.26 for homocysteine and from 0.81 to 1.06 for Lp(a). The results of this prospective population-based study do not support the hypotheses that serum homocysteine or Lp(a) are risk factors for atherosclerotic disease. The lack of association between serum homocysteine and atherosclerotic disease may be due to the exceptionally low gene frequency predisposing to homocysteinemia in Finland.

References (54)

  • G.M. Kostner et al.

    Lipoprotein Lp(a) and the risk for myocardial infarction

    Atherosclerosis

    (1981)
  • A. Murai et al.

    Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction

    Atherosclerosis

    (1986)
  • V.W. Armstrong et al.

    The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. De pendence on serum LDL levels

    Atherosclerosis

    (1986)
  • M. Jauhiainen et al.

    Lipoprotein(a) and coronary heart disease risk: a nested casecontrol study of the Helsinki Heart Study participants

    Atherosclerosis

    (1991)
  • A. Araki et al.

    Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

    J. Chromatogr.

    (1987)
  • S.H. Mudd et al.

    Disorders of transsulfuration

  • S.H. Mudd et al.

    Homocystinuria associated with decreased methylene-tetrahydrofolate reductase activity

    Biochem. Biophys Res. Commun.

    (1972)
  • C.S. Utley et al.

    Isolation and characterization of methionine synthetase from human placenta

    J. Biol. Chem.

    (1985)
  • P.M. Ueland et al.

    Plasma homocysteine, a risk factor for vascular disease. Plasma levels in health, disease, and drug therapy

    J. Lab. Clin. Med.

    (1989)
  • S.H. Mudd et al.

    The natural history of homocystinuria due to cystathionine 0-synthase deficiency

    Am. J. Hum. Genet.

    (1985)
  • L.W. Heinecke et al.

    The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells

    J. Biol. Chem.

    (1987)
  • L.A. Harker et al.

    Homocystinemia. Vascular injury and arterial thrombosis

    New Engl. J. Med.

    (1974)
  • S.S. Kang et al.

    Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

    J. Clin. Invest.

    (1986)
  • M.R. Malinow et al.

    Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease

    Circulation

    (1989)
  • M.R. Malinow et al.

    Homocyst(e)inemia in daily practice: levels in coronary artery disease

    Coron. Artery Dis.

    (1990)
  • J.B. Ubbink et al.

    The prevalence of homocystinemia and hypercholesterolemia in angio graphically defined coronary heart disease

    Klin. Wochenschr.

    (1991)
  • B.M. Coull et al.

    Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke

    Stroke

    (1990)
  • Cited by (523)

    • An Increased Serum Level of Lipoprotein(a) Is a Predictor for Deep Vein Thrombosis in Patients with Spinal Cord Injuries

      2016, World Neurosurgery
      Citation Excerpt :

      The combined model improved the ability of those biomarkers in predicting DVT risk compared with those alone (AUC of the combined model, 0.96; 95% CI, 0.93–0.98; P < 0.01). There was previous evidence regarding the association between high plasma Lp(a) levels and atherosclerotic disease,18,19 but only limited data are available on their effects on VTE. An Lp(a) is closely homologous with plasminogen,20 so that reduced fibrinolysis is considered to be the link between increased Lp(a) levels and thrombosis.

    • Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysis

      2015, Atherosclerosis
      Citation Excerpt :

      Pooled analysis of 4 studies [27,47,48,56] that reported data in women yielded a lower RR (pooled estimated OR = 1.49; 95% CI = 1.09–2.04; Q = 3.44; p = 0.39; I2 = 12.72%; see eFigure 3A in the supplement). Subgroup analysis of six prospective studies [25,50,51,59,60,62] that reported sex-specific data resulted in a pooled adjusted RR of 1.49 (95% CI = 1.10–2.03; Q = 12.18; p = 0.02; I2 = 67.15%) for women. There was moderate heterogeneity.

    View all citing articles on Scopus
    View full text